ArticleViruses2022

Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2.

Lia Fiaschi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.